Ovarian cancer Trials in Halle, Germany
Conditions / Ovarian cancer / Halle, Germany
Clinical trials for Ovarian cancer investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01444456 | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | COMPLETED | — |
| NCT04830709 | Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer | RECRUITING | — |
| NCT01388621 | Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer | UNKNOWN | PHASE2 |
| NCT00866697 | Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | COMPLETED | PHASE3 |
| NCT00418574 | Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients | TERMINATED | PHASE2/PHASE3 |
| NCT02477644 | Platine, Avastin and OLAparib in 1st Line | COMPLETED | PHASE3 |
| NCT00483782 | Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | COMPLETED | PHASE3 |
| NCT00003636 | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | COMPLETED | PHASE3 |
| NCT05009082 | Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer | RECRUITING | PHASE3 |
| NCT00002903 | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | COMPLETED | PHASE2 |